GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after ...

A groundbreaking study has revealed that GLP-1 receptor agonists—including popular weight-loss and diabetes drugs like ...

Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia.. The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

The researchers analyzed the weight loss of more than 18,000 adults who took Mounjaro or Ozempic between May 2022 and September 2023. By three months, Mounjaro patients shed 5.9% of their body ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...